FDA inspection
Hanmi Pharma Co., Ltd: FDA inspection ending Aug 2, 2024
FDA inspection 1248214 · Voluntary Action Indicated (VAI) · Pyeongtaek
Key facts
| Inspection ID | 1248214 |
|---|---|
| Firm | Hanmi Pharma Co., Ltd |
| FEI number | 3009350213 |
| Address | 114 Chupalsandan-Ro, Paengseong-Eup |
| City | Pyeongtaek |
| Country | Korea (the Republic of) |
| Fiscal year | 2024 |
| Inspection end date | Aug 2, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data